Document Detail

Use of transdermal clonidine in chronic hemodialysis patients.
MedLine Citation:
PMID:  8428405     Owner:  NLM     Status:  MEDLINE    
Large fluctuations of blood pressure are commonly experienced by hypertensive, chronic hemodialysis patients. Many patients hold anti-hypertensive medication immediately prior to dialysis to prevent intradialytic hypotension. Weekly dosing of continuously released antihypertensive agents may result in better blood pressure control than conventional daily dosing. To evaluate the effect of weekly transdermal clonidine on this problem, we compared intra- and interdialytic blood pressure control and side effects during six weeks of transdermal clonidine monotherapy and six weeks of conventional oral antihypertensive treatment in nine stable chronic hemodialysis patients. Since transdermal clonidine is recommended for mild to moderately severe hypertension and since clonidine is excreted by the kidneys and removed by hemodialysis, we also evaluated blood pressure control and clonidine levels while utilizing high-dose transdermal clonidine, up to 0.12 mg per week. Intradialytic blood pressure was monitored twice weekly during the weeks 3-6 of transdermal clonidine and conventional therapy. Twenty-four hour blood pressure was monitored weeks 3 and 6 of each study phase. Plasma clonidine levels were measured by HPLC in 11 patients. Transdermal clonidine monotherapy failed to adequately control blood pressure in 6 of 21 chronic dialysis patients with moderate to severe hypertension. No significant difference in intra- or interdialytic blood pressure control or side effects (including dry mouth or thirst) was found comparing conventional to transdermal clonidine therapy. While not statistically different, heart rate was lower during transdermal clonidine therapy compared to conventional therapy, especially at very high doses. Despite a mean hemodialysis clearance of clonidine of 59.2 +/- 7.8 ml/min, clonidine levels remained therapeutic beyond one week.(ABSTRACT TRUNCATED AT 250 WORDS)
S J Rosansky; K L Johnson; J McConnell
Related Documents :
2620855 - Pharmacologic evaluation of cardiovascular reflex responses in migraine patients: lack ...
11350495 - Acute renal failure in 2k2c goldblatt hypertensive rats during antihypertensive therapy...
24706595 - Concurrent tobacco and khat use is associated with blunted cardiovascular stress respon...
24674305 - The effect on anal pressure of percutaneous posterior tibial nerve stimulation for faec...
25201585 - Numerical and experimental analysis of factors leading to suture dehiscence after billr...
15910555 - Nurse-recorded clinic and ambulatory blood pressures correlate equally well with left v...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical nephrology     Volume:  39     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  1993 Jan 
Date Detail:
Created Date:  1993-03-05     Completed Date:  1993-03-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  32-6     Citation Subset:  IM    
Medical Services, WJB Dorn Veteran's Administration Hospital, Columbia, SC 29201.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Cutaneous
Administration, Oral
Antihypertensive Agents / administration & dosage,  therapeutic use
Blood Pressure / drug effects
Clonidine / administration & dosage*,  blood,  therapeutic use
Drug Administration Schedule
Heart Rate / drug effects
Hypertension, Renal / drug therapy*
Kidney Failure, Chronic / complications,  therapy*
Middle Aged
Renal Dialysis*
Reg. No./Substance:
0/Antihypertensive Agents; 4205-90-7/Clonidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chronic renal failure due to renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinur...
Next Document:  The use of transdermal clonidine in the hypertensive patient with chronic renal failure.